✦ LIBER ✦

Inhibition kinetics and selectivity of the tyrosine kinase inhibitor erbstatin and a pyridone-based analogue

✍ Scribed by Chin-Yi Jenny Hsu; Mary V. Jacoski; Martin P. Maguire; Alfred P. Spada; Asher Zilberstein

Book ID: 115782803
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 958 KB
Volume: 43
Category: Article
ISSN: 0006-2952
DOI: 10.1016/0006-2952(92)90327-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pyranone, Thiopyranone, and Pyridone Inh

Pyranone, Thiopyranone, and Pyridone Inhibitors of Phosphatidylinositol 3-Kinase Related Kinases. Structure−Activity Relationships for DNA-Dependent Protein Kinase Inhibition, and Identification of the First Potent and Selective Inhibitor of the Ataxia Telangiectasia Mutated Kinase

✍ Hollick, Jonathan J.; Rigoreau, Laurent J. M.; Cano-Soumillac, Celine; Cockcroft 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 310 KB

Structural Basis of Src Tyrosine Kinase

Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine-based Compounds

✍ David Dalgarno; Thilo Stehle; Surinder Narula; Pierre Schelling; Marie Rose van 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

The tyrosine kinase inhibitor dasatinib

The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo

✍ Kate Vandyke; Andrea L Dewar; Peter Diamond; Stephen Fitter; Christopher G Schul 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 423 KB

## Abstract Dasatinib is a potent tyrosine kinase inhibitor that is used to treat chronic myeloid leukemia in patients resistant or intolerant to imatinib mesylate. While designed to inhibit Abl and Src kinases, dasatinib shows multitarget effects, including inhibition of the macrophage colony‐stim

Structure-Based Design of a Potent, Sele

Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine Kinases

✍ Singh, Juswinder; Dobrusin, Ellen M.; Fry, David W.; Haske, Taraneh; Whitty, Adr 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 209 KB

The orally-active and selective c-Fms ty

The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model

✍ Hiroaki Ohno; Yasunori Uemura; Hideko Murooka; Hiromi Takanashi; Takemi Tokieda; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

Structure-Based Drug Design of RN486, a

Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis

✍ Lou, Yan; Han, Xiaochun; Kuglstatter, Andreas; Kondru, Rama K.; Sweeney, Zachary 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 426 KB